WallStreetZenWallStreetZen

NASDAQ: CGEM
Cullinan Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Cullinan Therapeutics earnings were -$180.1M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest CGEM earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$49.2M, up 1.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CGEM reported annual earnings of -$168.1M, with 9.3% growth.

CGEM earnings history

Current Revenue
$0.0
Current Earnings
-$180.1M
Current Profit Margin
0%

CGEM Return on Equity

Current Company
-29.7%
Current Industry
-59.8%
Current Market
28.7%
CGEM's Return on Equity (-29.7%)... subscribe to Premium to read more.
High Return on Equity Performance

CGEM undefined

Current Company
-28.4%
Current Industry
-1.4%
CGEM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CGEM announces earnings.

CGEM undefined

Current Company
-32.34%
Current Industry
5.8%
CGEM's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CGEM vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CGEM-$178.31M-$180.07MN/A-$2.66
TBPH-$39.82M-$58.33MN/A-$1.18
RGNX-$122.44M-$157.69MN/A-$3.10
FTRE-$577.60M-$790.40MN/A-$8.79
CELC-$101.37M-$111.78MN/A-$2.83
View Top Biotech Stocks

Cullinan Therapeutics Earnings Reports & History FAQ

What were Cullinan Therapeutics's earnings last quarter?

On CGEM's earnings call on Invalid Date, Cullinan Therapeutics (NASDAQ: CGEM) reported Q1 2025 earnings per share (EPS) of -$0.74, up 1.33% year over year. Total CGEM earnings for the quarter were -$49.16 million. In the same quarter last year, Cullinan Therapeutics's earnings per share (EPS) was -$0.75.

If you're new to stock investing, here's how to buy Cullinan Therapeutics stock.

Is Cullinan Therapeutics profitable or losing money?

As of the last Cullinan Therapeutics earnings report, Cullinan Therapeutics is currently losing money. Cullinan Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$178.74 million, a 35.05% increase year over year.

What was CGEM's earnings growth in the past year?

As of Cullinan Therapeutics's earnings date in Invalid Date, Cullinan Therapeutics's earnings has grown year over year. CGEM earnings in the past year totalled -$180.07 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.